These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9433528)

  • 1. Hypertension and coronary microvascular disease.
    Strauer BE; Schwartzkopff B
    Adv Exp Med Biol; 1997; 432():207-13. PubMed ID: 9433528
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.
    Motz W; Vogt M; Scheler S; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():100-6. PubMed ID: 1396852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications.
    Motz W; Vogt M; Strauer BE
    Clin Investig; 1993; 71(5 Suppl):S42-5. PubMed ID: 8518540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy: lodestar to stroke prevention in the treatment of hypertension?
    Kizer JR; Devereux RB
    Am J Hypertens; 2006 May; 19(5):439-42. PubMed ID: 16647610
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension and coronary heart disease.
    Baguet JP; Mallion JM
    Blood Press; 2003; 12(4):255-6. PubMed ID: 14596363
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy.
    Hansson L
    Adv Exp Med Biol; 1997; 432():189-90. PubMed ID: 9433525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension, Left Ventricular Hypertrophy, and Myocardial Ischemia.
    Stanton T; Dunn FG
    Med Clin North Am; 2017 Jan; 101(1):29-41. PubMed ID: 27884233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Normal blood pressure values in general practice are not enough. Also measure "morning after" values].
    MMW Fortschr Med; 2004 May; 146(19):62. PubMed ID: 15357487
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of left ventricular hypertrophy.
    Fagard R
    JAMA; 1996 Nov; 276(20):1636-7. PubMed ID: 8922446
    [No Abstract]   [Full Text] [Related]  

  • 13. [REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND LONG-TERM THERAPY WITH LOSARTAN].
    Dotsenko SY; Tokarenko AA; Tokarenko II
    Lik Sprava; 2015; (7-8):17-21. PubMed ID: 27491145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic effects of long-term hypertension control.
    Kaupke CJ
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 17-22. PubMed ID: 7634559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hypertensive heart (cardiac hypertension) and secondary drug prophylaxis].
    Metelitsa VI
    Ter Arkh; 1992; 64(9):112-6. PubMed ID: 1481146
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy.
    Liebson PR; Grandits G; Grimm RH
    JAMA; 1996 Aug; 276(7):526-7. PubMed ID: 8709396
    [No Abstract]   [Full Text] [Related]  

  • 18. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
    Clement DL; De Buyzere M; Duprez D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of LVH or improved prognosis (or both): what is the question?
    Lip GY; Lydakis C; Zarifis J; Messerli FH
    J Hum Hypertens; 1998 Jul; 12(7):423-5. PubMed ID: 9702926
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular hypertrophy in the dialysed patient. What can be done about it?
    Cannella G
    Nephrol Dial Transplant; 1996 Mar; 11(3):418-20. PubMed ID: 8671807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.